or Try an Advanced Search...

    Technical Analysis for ENSC - Ensysce Biosciences, Inc.

    Grade Last Price % Change Price Change
    C 0.66 -3.26% -0.02
    ENSC closed down 3.26 percent on Wednesday, November 20, 2024, on 3 percent of normal volume.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Very Strong Up Up Down
    Historical ENSC trend table...
    Date Alert Name Type % Chg
    MACD Bearish Signal Line Cross Bearish 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Wide Bands Range Expansion -3.26%
    Inside Day Range Contraction -3.57%
    Wide Bands Range Expansion -3.57%
    Calm After Storm Range Contraction -2.19%
    Wide Bands Range Expansion -2.19%
    Calm After Storm Range Contraction 3.15%
    Wide Bands Range Expansion 3.15%
    Older End-of-Day Signals for ENSC ...

       Recent Intraday Alerts

    Alert Time
    10 DMA Resistance about 21 hours ago
    Down 3% about 21 hours ago
    Fell Below Previous Day's Low about 21 hours ago
    Down 2 % about 21 hours ago
    Down 1% about 21 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    ENSC Chart by TradingView
    Basic chart:

    Profile

    Ensysce Biosciences, San Diego, CA is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. Leveraging its Trypsin Activated Abuse Protection (TAAP™) and Multi-Pill Abuse Resistance (MPAR™) platforms, the Company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Ensysce’s products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing the human and economic cost. The platforms are covered by an extensive worldwide intellectual property portfolio for a wide array of prescription drug compositions.
    Classification
    Sector: Industrials
    Industry: Conglomerates
    Keywords: Pain Health Sciences Pharmacy Psychoactive Drugs Opioids Heroin Morphine Opioid Use Disorder Drug Culture

    Is ENSC a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 15 Ensysce Biosciences Third Quarter 2024 Earnings: Beats Expectations
    Nov 13 ENSC Improves Position
    Nov 12 Ensysce Biosciences GAAP EPS of $0.07 beats by $0.24
    Nov 12 Ensysce Biosciences Reports Third Quarter 2024 Financial Results
    Nov 7 Ensysce Biosciences Receives Positive Nasdaq Listing Determination
    Nov 7 Why Lyft Shares Are Trading Higher By Over 21%; Here Are 20 Stocks Moving Premarket
    Oct 31 Why Carvana Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket
    Oct 30 Why Alphabet Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarket
    Oct 23 Why Stride Shares Are Trading Higher By Over 24%; Here Are 20 Stocks Moving Premarket
    Oct 8 Ensysce Biosciences Announces Leadership Team’s Participation in the Annual Pain Therapeutics Summit
    See more ENSC news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 2.06
    52 Week Low 0.1412
    Average Volume 33,545,253
    200-Day Moving Average 0.56
    50-Day Moving Average 0.39
    20-Day Moving Average 0.59
    10-Day Moving Average 0.68
    Average True Range 0.11
    RSI (14) 59.35
    ADX 54.9
    +DI 45.16
    -DI 12.63
    Chandelier Exit (Long, 3 ATRs) 0.64
    Chandelier Exit (Short, 3 ATRs) 0.64
    Upper Bollinger Bands 0.85
    Lower Bollinger Band 0.33
    Percent B (%b) 0.63
    BandWidth 87.64
    MACD Line 0.09
    MACD Signal Line 0.09
    MACD Histogram -0.0038
    Fundamentals Value
    Market Cap 2.06 Million
    Num Shares 3.15 Million
    EPS -1.86
    Price-to-Earnings (P/E) Ratio -0.35
    Price-to-Sales 1.15
    Price-to-Book 2.50
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.73
    Resistance 3 (R3) 0.74 0.72 0.72
    Resistance 2 (R2) 0.72 0.70 0.71 0.72
    Resistance 1 (R1) 0.69 0.68 0.67 0.68 0.71
    Pivot Point 0.66 0.66 0.66 0.66 0.66
    Support 1 (S1) 0.63 0.64 0.62 0.63 0.60
    Support 2 (S2) 0.61 0.63 0.61 0.59
    Support 3 (S3) 0.58 0.61 0.59
    Support 4 (S4) 0.58